肿瘤坏死因子α游离脂肪酸瘦素与胰岛素抵抗
被引量：2
出处
《河北医药》
CAS
2005年第9期689-690,共2页
Hebei Medical Journal
基金
为河北省卫生厅科研基金资助(No.01039)
参考文献16
-
1Patrik L,Vanessa VH,Signy R,et al.Secretion of tumor nesrosis factor-α shows a strong relationship to insulin-stimulated glucose transport in human adipose tissue.Diabetes,2000,49:688.
-
2Tartaglia LA,Goeddel DV,et al.Two TNF receptor.Immunol Today,1992,13:151-153.
-
3Smith CA,Farrah T,Goodwin RG,et al.The TNF receptor super-family of cellular and viral protein activation costimulation and death.Cell,1994,76:959-962.
-
4Vanddenabeele P,Peclerq W,Beyaert R,et al.Two tumor necrosis factor receptors:structure and function.Trends Cell Biol,1995,5:392-399.
-
5Hofmann C,Lorena K,Braithwaite SS,et al.Altered gene expression for tumor necrosis factor-α and its receptor during drug and dietary modulation of insulin resistancee.Endocrinology,1994,134:264-270.
-
6Hotamisligil GS,Amer P,Atkinso RL,et al.Differential regulation of the P80 tumor necrosis factor receptor in human obesity and insulin resistance.Diabetes,1997,46:451-455.
-
7Sen L,Martina S,Karin R,et al.Tumor necrosis factor-α acutely inhibits insulin signnaling in human adipoccytes.Diabetes,1998,47:515-522.
-
8Johannes B,Prins,Carloa U,et al.Tumor necrosis facctor-α induces apoptosis of human adipose cell.Diabetes,1998,47:1757-1761.
-
9Philip DG,Miles S,Oreste M,et al.TNF-α induced insulin resistance in vivo and prevention by trogiltazone.Diabetes,1997,46:1678-1683.
-
10Hotamisligil GS,Arner P,Caro JF,et al.Increased adipoes tissue expression of tumor necrosis factor-α in human obesity and insulin resistance.J Clin Invest,1995,95:2409-2415.
同被引文献21
-
1王燕.胰岛素抵抗的现代认识与治疗[J].河北医药,2004,26(11):908-909. 被引量：9
-
2Moussa MA, Shahout AA, Nkansd-Dwamena D, et al. Associationoffasting glucosel, and diabetes. The Athexesclexos Risk in Communities (ARIC) study. Diabetes Cqxe, 1997,20: 935-942.
-
3Grinsell JW, Lardioois CK, Swislocki A, et al. Pioglitazone attenuates basal and postprandial insulin concentrations and blood pressure in the spontaneously hypertensive rat. Am J Hypertension, 2000,13:370-375.
-
4Kim S, Yoshiyama M, Izumi Y, et al. Effects of combination of ACE inhibitor and angiotensin receptor blocker on cardiac remodling, cardiac function, and survival in rat heart failure. Circulation,2001,103:148-154.
-
5Reaven GM. Role of insulin resistance in human disease. Diabetes, 1988,37: 1595-1607.
-
6Fielding BA, Frayn KN. Lipoprotein lipase and disposition of dietary fatty acids. Br JNutr, 1998,80:495-502.
-
7Battilana P, See matter G, Schneiter P, et al. Effects of free fatty acids on insulin sensitivity and he modyna mics during mental stress. J Clin Endocrinol Metab,2001 ,86:124-128.
-
8Roden M, Shulman GI. Applications of NMR spectroscopy to study muscle glycogen metabolism in man. Annu Rev Med, 1999,50:277-290.
-
9Eriksson JW, Smith U, Waagstein F, et al. Glucose to mover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: cellular insulin resistance a secondary phenomenon. Diabetes, 1999,48 : 1572-1578.
-
10Miyashita Y, Shirai K, Yeshiaki L, et al. Low lipoprotein lipase mass in preheparin sermn of type 2 diabetes mellitus patients and its recovery with insulin therapy. Diabetes Res C lin P ract,2002,56:181-187.
引证文献2
-
1丁岚,张文真,白传明.性激素结合球蛋白、胰岛素抵抗与妊娠期高血压疾病发病关系的探讨[J].河北医药,2008,30(3):284-285.
-
2诸葛铭宁,蔡玉琴,斯重阳,张建芳,计承,马淑平.伊贝沙坦对胰岛素抵抗大鼠脂蛋白脂酶的影响[J].河北医药,2009,31(1):26-28. 被引量：1
-
1宋光明,孙静,谢文利.TNF-α所致的胰岛素抵抗[J].武警医学院学报,2004,13(6):491-493.
-
2E问医答[J].糖尿病之友,2012(6):74-74.
-
3高玉梅,马伟元,孙青.二甲双胍在皮肤病治疗中的应用进展[J].中华皮肤科杂志,2015,48(9):670-672. 被引量：2
-
4贾平.你了解格列酮类降糖药吗[J].糖尿病天地,2005(5):21-21.
-
5孙树果,范良敏,时立新.炎性因子与胰岛素抵抗[J].中国现代医药杂志,2006,8(11):142-144. 被引量：5
-
6陈欢欢,刘超.二甲双胍50年进程[J].国际内科学杂志,2008,35(10):573-577. 被引量：27
-
7刘颐轩,臧莎莎,宋光耀.二甲双胍分子机制的研究进展[J].中国糖尿病杂志,2015,23(4):375-377. 被引量：18
-
8周亚茹.2型糖尿病与游离脂肪酸的代谢与胰岛素抵抗[J].辽宁实用糖尿病杂志,2003,11(3):8-10. 被引量：8
-
9邹大进.改善胰岛素抵抗对治疗达标的贡献[J].中华医学信息导报,2005,20(8):23-23.
-
10糖尿病病人日夜24小时的“5段血糖周期”、前半夜低血糖敏感期[J].中国糖尿病杂志,2006,14(6):431-431.
